BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18535662)

  • 21. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
    Poole CJ; Lodh A; Choi JH; van Riggelen J
    Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Myc is Required for BRAF
    Qu Y; Yang Q; Liu J; Shi B; Ji M; Li G; Hou P
    Theranostics; 2017; 7(7):2092-2107. PubMed ID: 28656062
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
    Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc.
    Sharma VM; Calvo JA; Draheim KM; Cunningham LA; Hermance N; Beverly L; Krishnamoorthy V; Bhasin M; Capobianco AJ; Kelliher MA
    Mol Cell Biol; 2006 Nov; 26(21):8022-31. PubMed ID: 16954387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Necdin is a breast cancer metastasis suppressor that regulates the transcription of c-Myc.
    Lee M; Beggs SM; Gildea D; Bupp S; Lichtenberg J; Trivedi NS; ; Hu Y; Bodine DM; Crawford NP
    Oncotarget; 2015 Oct; 6(31):31557-68. PubMed ID: 26384308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular and cytological features of the mouse B-cell lymphoma line iMycEmu-1.
    Han SS; Shaffer AL; Peng L; Chung ST; Lim JH; Maeng S; Kim JS; McNeil N; Ried T; Staudt LM; Janz S
    Mol Cancer; 2005 Nov; 4():40. PubMed ID: 16277667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis.
    O'Donnell KA; Yu D; Zeller KI; Kim JW; Racke F; Thomas-Tikhonenko A; Dang CV
    Mol Cell Biol; 2006 Mar; 26(6):2373-86. PubMed ID: 16508012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.
    Liu H; Zhou M; Luo X; Zhang L; Niu Z; Peng C; Ma J; Peng S; Zhou H; Xiang B; Li X; Li S; He J; Li X; Li G
    BMC Mol Biol; 2008 Dec; 9():111. PubMed ID: 19111069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brief inactivation of c-Myc is not sufficient for sustained regression of c-Myc-induced tumours of pancreatic islets and skin epidermis.
    Pelengaris S; Abouna S; Cheung L; Ifandi V; Zervou S; Khan M
    BMC Biol; 2004 Dec; 2():26. PubMed ID: 15613240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changes.
    Sullivan DK; Deutzmann A; Yarbrough J; Krishnan MS; Gouw AM; Bellovin DI; Adam SJ; Liefwalker DF; Dhanasekaran R; Felsher DW
    Oncogene; 2022 Nov; 41(45):4960-4970. PubMed ID: 36207533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma.
    Ravi D; Beheshti A; Abermil N; Passero F; Sharma J; Coyle M; Kritharis A; Kandela I; Hlatky L; Sitkovsky MV; Mazar A; Gartenhaus RB; Evens AM
    Cancer Res; 2016 Jun; 76(11):3319-31. PubMed ID: 26988986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
    Wang Z; Ge L; Wang M; Carr BI
    J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An early Myc-dependent transcriptional program orchestrates cell growth during B-cell activation.
    Tesi A; de Pretis S; Furlan M; Filipuzzi M; Morelli MJ; Andronache A; Doni M; Verrecchia A; Pelizzola M; Amati B; Sabò A
    EMBO Rep; 2019 Sep; 20(9):e47987. PubMed ID: 31334602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMG-I/Y, a new c-Myc target gene and potential oncogene.
    Wood LJ; Mukherjee M; Dolde CE; Xu Y; Maher JF; Bunton TE; Williams JB; Resar LM
    Mol Cell Biol; 2000 Aug; 20(15):5490-502. PubMed ID: 10891489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancer.
    Shen H; Zhao L; Feng X; Xu C; Li C; Niu Y
    Oncotarget; 2016 Sep; 7(37):60407-60418. PubMed ID: 27494865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional genomic analysis reveals distinct neoplastic phenotypes associated with c-myb mutation in the bursa of Fabricius.
    Neiman PE; Grbiç JJ; Polony TS; Kimmel R; Bowers SJ; Delrow J; Beemon KL
    Oncogene; 2003 Feb; 22(7):1073-86. PubMed ID: 12592394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma.
    Zhou L; Picard D; Ra YS; Li M; Northcott PA; Hu Y; Stearns D; Hawkins C; Taylor MD; Rutka J; Der SD; Huang A
    Cancer Res; 2010 Oct; 70(20):8199-210. PubMed ID: 20876797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells.
    Doose G; Haake A; Bernhart SH; López C; Duggimpudi S; Wojciech F; Bergmann AK; Borkhardt A; Burkhardt B; Claviez A; Dimitrova L; Haas S; Hoell JI; Hummel M; Karsch D; Klapper W; Kleo K; Kretzmer H; Kreuz M; Küppers R; Lawerenz C; Lenze D; Loeffler M; Mantovani-Löffler L; Möller P; Ott G; Richter J; Rohde M; Rosenstiel P; Rosenwald A; Schilhabel M; Schneider M; Scholz I; Stilgenbauer S; Stunnenberg HG; Szczepanowski M; Trümper L; Weniger MA; ; Hoffmann S; Siebert R; Iaccarino I
    Proc Natl Acad Sci U S A; 2015 Sep; 112(38):E5261-70. PubMed ID: 26351698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state.
    Li Y; Choi PS; Casey SC; Dill DL; Felsher DW
    Cancer Cell; 2014 Aug; 26(2):262-72. PubMed ID: 25117713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice.
    Thakur A; Bollig A; Wu J; Liao DJ
    Mol Cancer; 2008 Jan; 7():11. PubMed ID: 18218118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.